Efficacy and side effects of haloperidol in psychotic patients: oral versus intravenous administration. 1982

H J Möller, and W Kissling, and C Lang, and P Doerr, and K M Pirke, and D von Zerssen

It is a commonly held view among clinicians that intravenously administered haloperidol has a greater antipsychotic effect than oral haloperidol. To test this hypothesis, the authors carried out a double-blind study on patients with acute schizophrenia and patients with schizophreniform or schizoaffective (with manic features) psychoses. Using biologically equivalent doses, they found that intravenously administered haloperidol was slightly more effective during the first 3 hours; thereafter the route of administration did not make a difference in effectiveness.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D011618 Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) Psychoses,Psychosis, Brief Reactive,Schizoaffective Disorder,Schizophreniform Disorders,Psychosis,Brief Reactive Psychoses,Brief Reactive Psychosis,Disorder, Psychotic,Disorder, Schizoaffective,Disorder, Schizophreniform,Disorders, Psychotic,Disorders, Schizoaffective,Disorders, Schizophreniform,Psychoses, Brief Reactive,Psychotic Disorder,Reactive Psychoses, Brief,Reactive Psychosis, Brief,Schizoaffective Disorders,Schizophreniform Disorder
D005260 Female Females
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H J Möller, and W Kissling, and C Lang, and P Doerr, and K M Pirke, and D von Zerssen
February 1997, Progress in neuro-psychopharmacology & biological psychiatry,
H J Möller, and W Kissling, and C Lang, and P Doerr, and K M Pirke, and D von Zerssen
January 1992, Psychopharmacology,
H J Möller, and W Kissling, and C Lang, and P Doerr, and K M Pirke, and D von Zerssen
February 2008, Progress in neuro-psychopharmacology & biological psychiatry,
H J Möller, and W Kissling, and C Lang, and P Doerr, and K M Pirke, and D von Zerssen
August 1967, International journal of neuropsychiatry,
H J Möller, and W Kissling, and C Lang, and P Doerr, and K M Pirke, and D von Zerssen
January 1980, International pharmacopsychiatry,
H J Möller, and W Kissling, and C Lang, and P Doerr, and K M Pirke, and D von Zerssen
August 1984, Pharmacology, biochemistry, and behavior,
H J Möller, and W Kissling, and C Lang, and P Doerr, and K M Pirke, and D von Zerssen
January 2024, Research square,
H J Möller, and W Kissling, and C Lang, and P Doerr, and K M Pirke, and D von Zerssen
August 1984, Revista medica de Chile,
H J Möller, and W Kissling, and C Lang, and P Doerr, and K M Pirke, and D von Zerssen
May 2003, Acta oto-laryngologica,
H J Möller, and W Kissling, and C Lang, and P Doerr, and K M Pirke, and D von Zerssen
January 1982, Acta psychiatrica Belgica,
Copied contents to your clipboard!